PacBio forecasts $155M-$165M 2026 revenue while shifting to a leaner structure and pushing SPRQ-Nx adoption

EarningsSPRQ-NxNeutral

AI Analysis

PacBio issued 2026 revenue guidance of $155M-$165M while implementing a leaner organizational structure and focusing on SPRQ-Nx product adoption.

Guidance

$155M-$165M

Importance:5/10

Sentiment:

0.20

guidancerestructuringproduct_adoptionrevenue_forecast

Related Companies

Read the original article

Published by Seeking Alpha Healthcare on August 6, 2026 5:31 AM